Compare BYND & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BYND | CVRX |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.6M | 253.2M |
| IPO Year | 2019 | 2021 |
| Metric | BYND | CVRX |
|---|---|---|
| Price | $1.22 | $9.03 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $1.70 | ★ $13.17 |
| AVG Volume (30 Days) | ★ 104.5M | 232.9K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $290,565,000.00 | $55,969,000.00 |
| Revenue This Year | N/A | $11.49 |
| Revenue Next Year | N/A | $16.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.44 |
| 52 Week Low | $0.50 | $4.30 |
| 52 Week High | $7.69 | $18.55 |
| Indicator | BYND | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.31 | 43.50 |
| Support Level | $1.15 | $8.82 |
| Resistance Level | $1.48 | $9.63 |
| Average True Range (ATR) | 0.16 | 0.67 |
| MACD | 0.07 | -0.07 |
| Stochastic Oscillator | 61.94 | 34.29 |
Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.